Single-stranded DNA, double-stranded DNA, RNA, modified oligos (e.g., 2'-OMe, LNA, phosphorothioate), aptamers, and antisense oligos.

Enzymes, antibodies, peptides, proteins, fluorophores, drugs, nanoparticles, polymers (PEG), lipids, and other small molecules.

We offer a broad range of advanced conjugation strategies, including chemical methods (e.g., amide coupling, thiol–maleimide reactions), enzymatic techniques (e.g., enzyme-catalyzed ligations), and biosynthetic approaches (e.g., non-natural amino acid incorporation). The optimal method is selected based on the biomolecule’s characteristics and the client’s specific requirements.

Yes. We offer flexible linker options—alkyl, PEG, cleavable, rigid, and functionalized—to meet specific solubility, stability, or release requirements.

Yes. We offer both site-specific and random conjugation options depending on the biomolecule and project goals.

You can supply your material, or we can source or produce it under controlled conditions.

Our conjugation technologies are designed to preserve both stability and bioactivity of the final products. We carefully control reaction conditions to avoid compromising the functional integrity of the biomolecules. Each conjugate undergoes rigorous quality testing to ensure it meets strict stability and performance criteria.

"Typically: HPLC profiles, MALDI-TOF or ESI-MS data, SDS-PAGE (for protein conjugates), UV-Vis absorbance, and functional bioassays (on request).

Through validated SOPs, real-time process monitoring, and strict QC release criteria using high-sensitivity analytical tools.

Standard projects: 2–3 weeks. Complex or custom chemistries may take 4–6 weeks depending on specifications and scale.

Match the chemistry to the available handles and the assay environment. For antibodies, maleimide–thiol (hinge or engineered Cys) and SPAAC are common; for peptides, NHS‑amine or maleimide–thiol; for surfaces, EDC/NHS or click. We can recommend an approach once we review your specs.

We tune molar ratios, reaction time, and quenching, then purify by SEC/HPLC. DoL is calculated by UV‑Vis (and/or MS) and reported on the COA.

For NHS couplings avoid primary amine buffers (e.g., Tris) and keep pH 7.5–8.5. For maleimide–thiol, avoid excess reducing agents (use TCEP at controlled levels). We will confirm optimal buffer during scoping.

Yes. We can work with customer‑supplied materials or source commercial equivalents under your approval.

Provide concentration, volume, buffer composition (salts, glycerol, detergents), presence of carrier proteins, and storage conditions. We may need to exchange buffers before conjugation.